
Emmaus Life Sciences Inc (QB) (EMMA)
USOTC
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease. Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0009 | -6.47482014388 | 0.0139 | 0.015 | 0.013 | 5367 | 0.01385963 | CS |
4 | -0.004 | -23.5294117647 | 0.017 | 0.0175 | 0.013 | 48441 | 0.01485187 | CS |
12 | -0.003 | -18.75 | 0.016 | 0.0199 | 0.012 | 38415 | 0.01511089 | CS |
26 | 0.0044 | 51.1627906977 | 0.0086 | 0.047 | 0.0086 | 41641 | 0.02144608 | CS |
52 | -0.087 | -87 | 0.1 | 0.1 | 0.0001 | 54215 | 0.01553286 | CS |
156 | -0.412 | -96.9411764706 | 0.425 | 0.59 | 0.0001 | 33266 | 0.11778719 | CS |
260 | -1.637 | -99.2121212121 | 1.65 | 4 | 0.0001 | 26031 | 0.50396159 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.